
Autoliv reported a strong Q4 2025 with net sales of $2,817m (+7.7% YOY, 4.2% organic) and record quarterly operating cash flow of $544m (+30%); full-year sales were $10,815m (+4.1%). Operating income declined to $319m (11.3% margin) while adjusted operating income was $337m (12.0% adjusted margin); diluted EPS was $2.98 (adjusted $3.19). The company delivered robust free cash flow, improved leverage to 1.1x, paid a $0.87 dividend and repurchased 1.26m shares; guidance for 2026 calls for around 0% organic growth, ~1% FX tailwind and a ~10.5–11.0% adjusted operating margin with ~$1.2bn expected operating cash flow. Strong product launches and ~40% Q4 growth to Chinese OEMs underpinned performance and underpin confidence despite guidance for muted top-line growth next year.
Market structure: Autoliv (ALV) is winning share in China/India and with COEMs — Q4 organic +4.2% vs global LVP +1.3%, COEM sales ~+40% in Q4 and 23% CY — which shifts pricing power toward ALV for safety/AD modules where barriers to entry (engineering, validation, certification) are high. Competitors with limited China/COEM footprints will see margin pressure; tier-1s tied to mature-market LVPs face slower top-line. The recovery of tariff pass-through (~100% Q4, >80% FY) implies ALV can protect margins against trade shocks better than peers, tightening supply-demand for qualified safety suppliers. Risk assessment: Near-term risk is execution on Q1 (company warns materially weaker Q1 margins) and FX volatility (guidance assumes +1% FX on sales); tail risks include Chinese policy reversal on COEM incentives, antitrust rulings (company already flags exclusions), or a large warranty/recall — any of which could cut ROCE from 30% toward mid-teens. Time horizons: days–weeks: volatility around Apr 17 Q1 report; months: margin recovery narrative plays into H2 2026; years: structural gains from AD/foldable steering wheel if regulatory certification/scale achieved. Hidden dependency: 30% order intake from COEMs creates customer concentration risk and potential IP/transfer exposure. Trade implications: Tactical: establish a 2–3% long position in ALV on any >6–8% pullback into late-April (post Q1) targeting +15–25% to end-2026 if adjusted margin rebounds to ~12% and multiple rerates; set 12% stop-loss. Relative value: pair long ALV (2%) vs short APTV (1–1.5%) over 6–12 months — ALV benefits from China/COEM wins while APTV is more exposed to software/EV cyclicality. Options: buy a Jul–Dec 2026 call spread (25–40% OTM) to play H2 margin recovery with defined risk; alternatively sell near-term puts after the Q1 selloff to collect premium while targeting average entry. Contrarian angles: Consensus may underprice durability of COEM relationships — 30% order intake and strategic engineering footprint suggest sustained higher ASPs, but market likely overweights Q1 softness; that creates asymmetric upside into H2. Conversely, downside is underappreciated: COEM concentration and potential Chinese regulatory nationalism or IP transfer demands could inflict outsized long-term damage. Historical parallel: suppliers that localized early in China (Bosch, ZF) captured multi-year share gains; if ALV’s foldable-steering IP proves commercial, multiples could expand materially, but certification delays are a 6–18 month kill-switch.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.52
Ticker Sentiment